Connect with us


WHO Warns BA5 COVID Subvariant Spreading At A “Very Intense Level”

Although the world has been largely operating on a pre-pandemic normal for the past few months, there are indications that may soon change. Today, the…



Although the world has been largely operating on a pre-pandemic normal for the past few months, there are indications that may soon change. Today, the World Health Organization (WHO) warned that the highly transmissible BA5 COVID subvariant of Omicron spreads at a “very intense level”, currently being reflected in several rising case hotspots around the world.

At a news conference on Tuesday, Dr. Tedros Adhanom Ghebreyesus conveyed his message in his usual unflinching demeanor. In a six minute opening address, The WHO Director-General reiterated his concern that “cases of COVID-19 continue to rise, putting further pressure on stretched health systems,” while affirming the trend that transmissions are increasing. This is consistent with the organization’s emergency committee on COVID-19 last Friday which concluded that the virus remains a public health threat.

The virus is running freely and countries are not effectively managing the disease burden… New waves of the virus demonstrate again that COVID-19 is nowhere near over.

WHO Director-General Tedros Adhanom

Overall, WHO is reporting a 30 percent rise in cases over the last two weeks, despite widespread uptake in vaccine participation in G20 nations and presumed occurrence of natural infections in the general population. This is consistent with data being reported in media outlets and social media, which show COVID infections spiking in jurisdictions throughout the globe:

On Monday, Bloomberg reported that the US government will again extend the Covid-19 public health emergency on July 15, continuing measures that have given millions of Americans special access to health insurance and telehealth services. The Department of Health and Human Services has repeatedly renewed the emergency since it was originally declared in January 2020, and signals that health authorities remain concerned about the threat of COVID.

Meanwhile on July 12, the White House COVID-19 team announced its strategy to manage BA5 COVID. The strategy relies on ensuring that Americans continue to have convenient access to the vaccines, treatments, tests, and other tools that protect against and treat the virus. The aim is to prevent serious illness, keep people out of the hospital, and save lives.

Small Cap Stocks That Could See Renewed Interest From The BA5 COVID Wave

Adamis Pharmaceuticals (ADMP) is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas. In focus currently is the their COVID drug candidate Tempol, which is currently in Phase 2/3 clinical trials. At last update, the Data Safety Monitoring Board overseeing the trial has met on May 31 to evaluate interim clinical and safety data and determined that the study can continue as planned.

According to, the estimated study completion date is September 30, 2020.

The company’s SYMJEPI (epinephrine) and ZIMHI (naloxone) injection products are approved by the FDA for use in the emergency treatment of acute allergic reactions, and opioid overdose, respectively.

Revive Therapeutics (RVVTF) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company has processed 715 patients from its Phase 3 clinical trial to evaluate Bucillamine to treat hospitalizations and death due to COVID, and is currently studying the possibility for endpoint change submission to the FDA in order to expedite a favorable clinical outcome.

Should Revive seek endpoint change approval from the FDA—in combination with strong data from its processed pool of patients—it’s possible that a trial resolution could happen within weeks, without the need to continue the scheduled 1000-patient study. The company has previously stated that its Data Safety Monitoring Board is “scheduled to meet thereafter (possible FDA endpoint change approval) to… make a recommendation on continuing the study or advise on halting the study early due to positive efficacy based on other clinical outcomes.”

Therma Bright (THRM.VN) is a medical diagnostic and device technology company focused on providing consumers and medical professionals with innovative healthcare solutions. On March 29, 2022, the company submitted a FDA Emergency Use Authorization application for Point-of-Care Use for its AcuVid COVID-19 Rapid Antigen Saliva Test. While on June 23, 2022, Therma Bright announced the submission of its Health Canada application for the same device.

Therma Bright’s self-administered AcuVid antigen test is purportedly easier and less invasive by using saliva spit instead of nasal swabs to detect the presence of the COVID-19 disease. The company has previously announced that its final U.S. clinical performance study data submitted exceeded the FDA EUA minimum requirements.

With BA5 COVID once again heating up, the antigen test maker could receive investor interest if it’s able to procure FDA and/or Health Canada approval for its flagship antigen test.

Well Health Technologies (WELL.TO) is a practitioner-focused digital health company which has built an innovative enablement services that includes comprehensive practice management tools inclusive of virtual care and digital patient engagement capabilities. WELL’s telehealth platform connects patients to physicians through video, phone and secure messaging.

A darling during the original COVID pandemic, Well Health has declined around two-thirds since its February 2021 high. It would not be surprising to see digital health stocks rally once more if the BA5 COVID variant turns out to be as infectious as many experts anticipate.

The post WHO Warns BA5 COVID Subvariant Spreading At A “Very Intense Level” appeared first on The Dales Report.

Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Spread & Containment

$265 Billion In Added Value To Evaporate From Germany Economy Amid Energy Crisis, Study Warns

$265 Billion In Added Value To Evaporate From Germany Economy Amid Energy Crisis, Study Warns

A new report published by the Employment Research…



$265 Billion In Added Value To Evaporate From Germany Economy Amid Energy Crisis, Study Warns

A new report published by the Employment Research (IAB) on Tuesday outlines how Germany's economy will lose a whopping 260 billion euros ($265 billion) in added value by the end of the decade due to high energy prices sparked by Russia's invasion of Ukraine which will have severe ramifications on the labor market, according to Reuters

IAB said Germany's price-adjusted GDP could be 1.7% lower in 2023, with approximately 240,000 job losses, adding labor market turmoil could last through 2026. It expects the labor market will begin rehealing by 2030 with 60,000 job additions.

The report pointed out the hospitality industry will be one of the biggest losers in the coming downturn that the coronavirus pandemic has already hit. Consumers who have seen their purchasing power collapse due to negative real wage growth as the highest inflation in decades runs rampant through the economy will reduce spending. 

IAB said energy-intensive industries, such as chemical and metal industries, will be significantly affected by soaring power prices. 

In one scenario, IAB said if energy prices, already up 160%, were to double again, Germany's economic output would crater by nearly 4% than it would have without energy supply disruptions from Russia. Under this assumption, 660,000 fewer people would be employed after three years and still 60,000 fewer in 2030. 

This week alone, German power prices hit record highs as a heat wave increased demand, putting pressure on energy supplies ahead of winter. 

Rising power costs are putting German households in economic misery as economic sentiment across the euro-area economy tumbled to a new record low. What happens in Germany tends to spread to the rest of the EU. 

There are concerns that a sharp weakening of growth in Germany could trigger stagflation as German inflation unexpectedly re-accelerated in July, with EU-Harmonized CPI rising 8.5% YoY. 

Germany is facing an unprecedented energy crisis as Russian natural gas cuts via the Nord Stream 1 pipeline will reverse the prosperity many have been accustomed to as the largest economy in Europe. 

"We are facing the biggest crisis the country has ever had. We have to be honest and say: First of all, we will lose the prosperity that we have had for years," Rainer Dulger, head of the Confederation of German Employers' Associations, warned last month. 

Besides Dulger, Economy Minister Robert Habeck warned of a "catastrophic winter" ahead over Russian NatGas cut fears.

Other officials and experts forecast bankruptcies, inflation, and energy rationing this winter that could unleash a tsunami of shockwaves across the German economy.  

Yasmin Fahimi, the head of the German Federation of Trade Unions, warned last month:

"Because of the NatGas bottlenecks, entire industries are in danger of permanently collapsing: aluminum, glass, the chemical industry." 

IAB's report appears to be on point as the German economy seems to be diving head first into an economic crisis. Much of this could've been prevented, but Europe and the US have been so adamant about slapping Russia with sanctions that have embarrassingly backfired. 

Tyler Durden Wed, 08/10/2022 - 04:15

Read More

Continue Reading


“Anything But A Cashless Society”: Physical Money Makes Comeback As UK Households Battle Inflation

"Anything But A Cashless Society": Physical Money Makes Comeback As UK Households Battle Inflation

The World Economic Forum (WEF) has been…



"Anything But A Cashless Society": Physical Money Makes Comeback As UK Households Battle Inflation

The World Economic Forum (WEF) has been pushing hard for a 'cashless society' in a post-pandemic world, though physical money has made a comeback in at least one European country as consumers increasingly use notes and coins to help them balance household budgets amid an inflationary storm

Britain's Post Office released a report Monday that revealed even though the recent accelerated use of cards and digital payments on smartphones, demand for cash surged this summer, according to The Guardian. It said branches handled £801mln in personal cash withdrawals in July, an increase of 8% over June. The yearly change on last month's figures was up 20% versus the July 2021 figure of £665mln.

Across the Post Office's 11,500 branches, £3.31bln in cash was deposited and withdrawn in July -- a record high for any month dating back over three centuries of operations. 

The report pointed out that increasing physical cash demand was primarily due to more people managing their budgets via notes and coins on a "day-by-day basis." It said some withdrawals were from vacationers needing cash for "staycations" in the UK. About 600,000 cash payouts totaling £90mln were from people who received power bill support from the government, the Post Office noted. 

Britain is "anything but a cashless society," according to the Post Office's banking director Martin Kearsley.

"We're seeing more and more people increasingly reliant on cash as the tried and tested way to manage a budget. Whether that's for a staycation in the UK or if it's to help prepare for financial pressures expected in the autumn, cash access in every community is critical," Kearsley said.

We noted in February 2021, UK's largest ATM network saw plummeting demand as consumers reduced cash usage. At the time, we asked this question: "How long will the desire for good old-fashioned bank notes last?

... and the answer is not long per the Post Office's new report as The Guardian explains: "inflation going up and many bills expected to rise further – has led a growing numbers of people to turn once again to cash to help them plan their spending." 

So much for WEF, central banks, and major corporations pushing for cashless societies worldwide, more importantly, trying to usher in a hyper-centralized CBDC dystopia. With physical cash back in style in the UK, the move towards a cashless society could be a much more challenging task for elites than previously thought. 

Tyler Durden Wed, 08/10/2022 - 02:45

Read More

Continue Reading


Something Just Doesn’t Add Up In Chinese Trade Data

Something Just Doesn’t Add Up In Chinese Trade Data

By Ye Xie, Bloomberg markets live commentator and reporter

An unusual discrepancy has…



Something Just Doesn’t Add Up In Chinese Trade Data

By Ye Xie, Bloomberg markets live commentator and reporter

An unusual discrepancy has showed up in two sets of trade data in China. Depending on which official sources you use, China’s trade surplus, could either be overstated or under-reported by a staggering $166 billion over the past year.

China watchers cannot fully explain the mystery. It’s as if Chinese residents bought a lot of stuff overseas, and instead of shipping the items home, they were kept abroad for some reason.  

China’s exports have been surprisingly resilient, despite a slowing global economy and Covid disruptions. On Monday, General Administration of Customs data showed China’s exports increased 18% in July from a year earlier. In contrast, imports grew only 2.3%, reflecting weak domestic demand.

The result is China’s trade surplus keeps swelling, which has underpinned the yuan by offsetting capital outflows. The surplus over the past year amounted to a record $864 billion, more than double the level at the end of 2019.

But when comparing the Customs data with that from the State Administration of Foreign Exchange (SAFE), a different picture emerges. The SAFE data shows the surplus is growing at a much slower pace -- about 20% less than the customs figure

The two data sets used to track each other closely. SAFE typically reports fewer imports, thus a higher surplus, because it excludes costs, insurance and freight from the value of goods imported, in line with the international standard practice, Adam Wolfe, an economist at Absolute Strategy Research, noted.

The other adjustments that SAFE does include:

  • It only records transactions that involve a change of ownership;
  • It adjusts for returned items;
  • It adds goods bought and resold abroad that don’t cross China’s border, but result in income for a Chinese entity -- a practice known  as “merchanting.”

The relationship between the two data sets has flipped since 2021, as SAFE reported higher imports, resulting in a smaller surplus than the Customs data.

It’s particularly odd because it happened at a time when shipping costs skyrocketed. When SAFE removes freight and insurance costs, it would have resulted in even lower, not higher, imports.

Taken at face value, the discrepancy suggests that somebody in China “bought” lots of goods from abroad, but they have never arrived in China. These transactions would be recorded by SAFE as imports, but not at the Customs office.

Craig Botham at Pantheon Macroeconomics, suspects that Covid-19 may be playing a role here. Foreign firms unable to manufacture in factories elsewhere during the pandemic might have transferred materials to China for assembly, a transaction excluded by SAFE.

Could Chinese buyers overstate their foreign purchases to SAFE, which regulates the capital account, so they can move money out of the country? The cross-border transactions show there was widespread overpaying for imports in 2014-2015, during a period of intense capital flight, but not at the moment, Wolfe pointed out.

Source: Absolute Strategy Research

The bottom line is that there aren’t many good explanations. As Alex Etra, a senior strategist at Exante Data, said, there’s “no smoking gun” to suggest something fishy is going on.

It’s another mysterious puzzle waiting to be solved.

Tyler Durden Tue, 08/09/2022 - 22:28

Read More

Continue Reading